AR088358A1 - Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos - Google Patents

Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos

Info

Publication number
AR088358A1
AR088358A1 ARP120103859A ARP120103859A AR088358A1 AR 088358 A1 AR088358 A1 AR 088358A1 AR P120103859 A ARP120103859 A AR P120103859A AR P120103859 A ARP120103859 A AR P120103859A AR 088358 A1 AR088358 A1 AR 088358A1
Authority
AR
Argentina
Prior art keywords
obtaining
isoxazolil
metoxi
nicotinic acids
compound
Prior art date
Application number
ARP120103859A
Other languages
English (en)
Spanish (es)
Inventor
Dott Pascal
Paul Hanlon Steven
Hildbrand Stefan
Iding Hans
Thomas Andrew
Waldmeier Pius
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR088358A1 publication Critical patent/AR088358A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001Nitrilase (3.5.5.1)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP120103859A 2011-10-20 2012-10-17 Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos AR088358A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11185992 2011-10-20

Publications (1)

Publication Number Publication Date
AR088358A1 true AR088358A1 (es) 2014-05-28

Family

ID=47019026

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120103859A AR088358A1 (es) 2011-10-20 2012-10-17 Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos

Country Status (20)

Country Link
US (1) US8604062B2 (https=)
EP (1) EP2768827B1 (https=)
JP (1) JP5923174B2 (https=)
KR (2) KR20140084209A (https=)
CN (1) CN103889978B (https=)
AR (1) AR088358A1 (https=)
AU (1) AU2012321095B2 (https=)
BR (1) BR112014009266B1 (https=)
CA (2) CA3112072C (https=)
DK (1) DK2768827T3 (https=)
ES (1) ES2613802T3 (https=)
HU (1) HUE031276T2 (https=)
IL (1) IL231645A (https=)
MX (1) MX2014004688A (https=)
MY (1) MY164880A (https=)
PL (1) PL2768827T3 (https=)
RU (1) RU2014118966A (https=)
SG (1) SG11201401626UA (https=)
SI (1) SI2768827T1 (https=)
WO (1) WO2013057123A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004116A2 (pt) * 2017-08-28 2020-09-01 University Of Maryland, Baltimore novos moduladores do receptor de ácido gama aminobutírico tipo a para distúrbios de humor
IL279266B2 (en) 2018-06-13 2024-03-01 Hoffmann La Roche New isoxazolyl ether derivatives as gaba a alpha5 pam
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
EP4126858B1 (en) 2020-03-26 2026-03-18 Richter Gedeon Nyrt. Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators
GB202013765D0 (en) * 2020-09-02 2020-10-14 Gw Res Ltd Method of preparing cannabinoids
CN116854680A (zh) 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途
CN119265168B (zh) * 2024-11-05 2025-06-20 江南大学 一种新型腈水解酶及其在烟酸生物合成中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1102755B1 (en) 1998-08-07 2006-01-04 Chiron Corporation Substituted isoxazole derivatives as estrogen receptor modulators
US6551804B2 (en) * 1999-07-12 2003-04-22 E. I. Du Pont De Nemours And Company Process for preparing 4-cyanopentanoic acid
US20060148858A1 (en) 2002-05-24 2006-07-06 Tsuyoshi Maekawa 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
WO2005113519A1 (en) 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
ATE415385T1 (de) 2004-10-01 2008-12-15 Hoffmann La Roche Hexafluorisopropanolsubstituierte etherderivate
DE602006017694D1 (de) 2005-06-27 2010-12-02 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
EP1931661B1 (en) 2005-09-19 2008-11-19 F.Hoffmann-La Roche Ag Isoxazolo derivatives as gaba a alpha5 inverse agonists
WO2007042420A1 (en) 2005-10-11 2007-04-19 F. Hoffmann-La Roche Ag Isoxazole derivatives
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
WO2009071464A1 (en) 2007-12-04 2009-06-11 F. Hoffmann-La Roche Ag Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
UA100132C2 (en) * 2007-12-04 2012-11-26 Ф. Хоффманн-Ля Рош Аг Isoxazolo-pyridine derivatives
JP2012040448A (ja) * 2008-11-14 2012-03-01 Yasutaka Sakamoto マイクロバブル発生装置
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
MX2011011484A (es) 2009-05-07 2011-11-18 Hoffmann La Roche Derivados de isoxazol-piridina como moduladores del acido gamma-aminobutirico.

Also Published As

Publication number Publication date
WO2013057123A1 (en) 2013-04-25
PL2768827T3 (pl) 2017-05-31
KR20200008671A (ko) 2020-01-28
CA2850440C (en) 2021-05-04
EP2768827A1 (en) 2014-08-27
KR20140084209A (ko) 2014-07-04
JP5923174B2 (ja) 2016-05-24
IL231645A (en) 2016-09-29
BR112014009266A2 (pt) 2017-06-13
BR112014009266B1 (pt) 2021-05-04
DK2768827T3 (en) 2017-02-13
JP2014530831A (ja) 2014-11-20
US20130102778A1 (en) 2013-04-25
AU2012321095B2 (en) 2015-08-20
BR112014009266A8 (pt) 2020-04-22
KR102262697B1 (ko) 2021-06-11
RU2014118966A (ru) 2015-11-27
CA3112072C (en) 2023-06-13
NZ622214A (en) 2016-08-26
CA3112072A1 (en) 2013-04-25
HUE031276T2 (hu) 2017-07-28
MY164880A (en) 2018-01-30
ES2613802T3 (es) 2017-05-26
CN103889978B (zh) 2017-02-15
CN103889978A (zh) 2014-06-25
CA2850440A1 (en) 2013-04-25
SG11201401626UA (en) 2014-05-29
AU2012321095A1 (en) 2013-05-09
IL231645A0 (en) 2014-05-28
US8604062B2 (en) 2013-12-10
EP2768827B1 (en) 2016-11-23
SI2768827T1 (sl) 2017-04-26
MX2014004688A (es) 2014-05-28

Similar Documents

Publication Publication Date Title
AR088358A1 (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos
AR098343A1 (es) Proceso para la síntesis de un inhibidor de indolamina 2,3-dioxigenasa
IN2014MN02496A (https=)
AR091246A1 (es) Procesos para producir 2-(piridin-3-il)tiazoles
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
AR094948A1 (es) Preparación de haloalcoxiarilhidracinas y los intermediarios a partir de los mismos
AR095727A1 (es) Preparación de intermediarios de pirimidina
AR090566A1 (es) Proceso para la produccion de inhibidores de crr
AR090172A1 (es) Proceso para la preparacion de carboxamidas
AR105494A1 (es) Método para preparar derivados de ácido 3-(2-anilino-1-ciclohexil-1h-bencimidazol-5-il)propanoico sustituido
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
NI201200195A (es) Procedimiento de preparación de la sal de l - arginina de perindoprilo
EA201490998A1 (ru) Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты
AR092355A1 (es) Fluoruros de fluoropicolinoilo y procesos para su preparacion
AR094954A1 (es) Preparación de 1,3-(diarilo sustituido)-1,2,4-triazoles e intermediarios derivados de ellos
AR098879A1 (es) Síntesis de ent-progesterona y sus productos intermedios
CO6700822A2 (es) Proceso para preparar 3-haloalquilporazoles
NI201300062A (es) Procedimiento e intermedios de síntesis de la agomelatina
BR112015026759A2 (pt) síntese de inibidores bace
BR112015019305A2 (pt) processo para a produção de composto de piridazinona e seus intermediários de produção
NI201200039A (es) Nuevos derivados dihidro - oxazolobenzodiazepinonas, su procedi
ES2721446T3 (es) Método para producir un compuesto de éster del ácido ciclopropano carboxílico ópticamente activo, un complejo de cobre asimétrico y un compuesto de salicilidenoaminoalcohol ópticamente activo
AR093901A1 (es) Proceso mejorado para la preparacion de determinadas sulfiliminas sustituidas
MX2017004815A (es) Metodo para la polimeracion de acido (met)acrilico en solucion.
AR093947A1 (es) Un proceso mejorado para la eliminacion del paladio desde 4-amino-3-halo-5-fluor-6-(aril)piridina-2-carboxilatos y 4-amino-3-halo-6-(aril)piridina-2-carboxilatos

Legal Events

Date Code Title Description
FG Grant, registration